Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
369
datasets available to search
ShareScore release 0.9.0
Dataset results
369 results for “adalimumab”
A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease
ClinicalTrials.gov study NCT00445939. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT00298272. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Abatacept Versus Adalimumab Head-to-Head
ClinicalTrials.gov study NCT00929864. IPD Sharing: Not stated. Countries: 5. Publications: 9.
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
ClinicalTrials.gov study NCT01004432. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
ClinicalTrials.gov study NCT01295814. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
ClinicalTrials.gov study NCT00574249. IPD Sharing: Not stated. Countries: 15. Publications: 1.
A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis
ClinicalTrials.gov study NCT01119859. IPD Sharing: Not stated. Countries: 15. Publications: 4.
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
ClinicalTrials.gov study NCT00385736. IPD Sharing: Not stated. Countries: 13. Publications: 4.
A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab
ClinicalTrials.gov study NCT01502423. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheum
ClinicalTrials.gov study NCT03104400. IPD Sharing: YES. Countries: 46. Publications: 14.
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Ac
ClinicalTrials.gov study NCT02760407. IPD Sharing: Not stated. Countries: 18. Publications: 1.
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF
ClinicalTrials.gov study NCT02171429. IPD Sharing: Not stated. Countries: 19. Publications: 2.
A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
ClinicalTrials.gov study NCT02814175. IPD Sharing: YES. Countries: 14. Publications: 1.
Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab
ClinicalTrials.gov study NCT01927757. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
ClinicalTrials.gov study NCT03151551. IPD Sharing: YES. Countries: 22. Publications: 6.
Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy
ClinicalTrials.gov study NCT00566722. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
ClinicalTrials.gov study NCT01543204. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis
ClinicalTrials.gov study NCT00870467. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT01185301. IPD Sharing: Not stated. Countries: 10. Publications: 3.
Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
ClinicalTrials.gov study NCT00538902. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.